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Background: Renal ischemia-reperfusion injury (IRI) increases the rates of acute kidney failure, delayed graft
function, and early mortality after kidney transplantation. The pathophysiology involved includes oxidative stress,
mitochondrial dysfunction, and immune-mediated injury. The anti-oxidation, anti-apoptosis, and anti-inflammation
properties of baicalin, a flavonoid glycoside isolated from Scutellaria baicalensis, have been verified. This study therefore
assessed the effects of baicalin against renal IRI in rats.
Methods: Baicalin was intraperitoneally injected 30 min before renal ischemia. Serum and kidneys were
harvested 24 h after reperfusion. Renal function and histological changes were assessed. Markers of oxidative
stress, the Toll-like receptor (TLR)2 and TLR4 signaling pathway, mitochondrial stress, and cell apoptosis were
also evaluated.
Results: Baicalin treatment decreased oxidative stress and histological injury, and improved kidney function, as
well as inhibiting proinflammatory responses and tubular apoptosis. Baicalin pretreatment also reduced the
expression of TLR2, TLR4, MyD88, p-NF-κB, and p-IκB proteins, as well as decreasing caspase-3 activity and
increasing the Bcl-2/Bax ratio.
Conclusions: Baicalin may attenuate renal ischemia-reperfusion injury by inhibiting proinflammatory responses
and mitochondria-mediated apoptosis. These effects are associated with the TLR2/4 signaling pathway and
mitochondrial stress.
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Renal ischemia-reperfusion injury (IRI), a proinflammatory
pathophysiological process, can increase the rates of acute
kidney failure, delayed graft function, and early mortality in
patients undergoing kidney transplantation [1]. Baicalin is a
flavonoid glycoside isolated from Scutellaria baicalensis [2].
This root, which has anti-bacterial and anti-inflammatory
properties, is a traditional Chinese herb widely used in the
treatment of infectious and inflammatory diseases. Baicalin
has been shown to possess these protective properties as
well, including against various inflammatory diseases [3-5].
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reproduction in any medium, provided the orvarious organs, including the heart [6], liver [7], and brain
[8], because of its anti-oxidative, anti-inflammatory, and
anti-apoptotic effects. However, its impact on renal IRI
remains unknown.
Baicalin may protect against IRI by altering the produc-
tion of various mediators, including reactive oxygen species
(ROS), Toll-like receptor (TLR)2 and TLR4, NF-κB, Bax,
and Bcl-2. Oxidative stress is significantly ameliorated after
baicalin treatment [9,10]. Baicalin has been shown to
down-regulate the expression of TLR2, enhance the
expression of Bcl-2, and inhibit the activities of Bax and
caspase-3 in mastitis [11]. Moreover, baicalin was found
to reduce the expression of TLR2/4 and NF-κB, thus inhi-
biting the TLR2/4 signaling pathway [12].
Oxidative stress, the TLR2/4 signaling pathway, and
mitochondrial stress play important roles in renal IRI. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to be the main reason for uncontrolled oxidative stress,
which leads to changes in expression of Bcl-2 and Bax,
which are markers of mitochondrial dysfunction [15].
Renal injuries result in the release of heat shock proteins,
high mobility group box 1, and other breakdown products,
which subsequently bind to TLRs 2 and 4 as endogen-
ous ligands and induce active immune-mediated injury
in damage-associated molecular patterns. TLR activation
results in an intracellular cascade of events, during which
MyD88-dependent signaling leads to the release of NF-κB
from IκB, allowing NF-κB translocation from the cytoplasm
to the nucleus, where it mediates the increased expression
of inflammatory cytokine genes, leading to a proinflamma-
tory response [16,17]. The direct loss of renal function after
IRI is associated with the apoptosis of tubular epithelial
cells (TECs), a process that can be induced by increased
expression of proinflammatory cytokines or mitochondrial
dysfunction.
The close association between the mechanisms of renal
IRI and baicalin protection suggested that baicalin may
be effective in protecting against renal IRI. To test this
hypothesis, we used a rat model of renal IRI. The aims
of this study were: (1) to confirm that baicalin treatment
protects against renal IRI; (2) to investigate the effects
of baicalin on the expression of TLR2 and TLR4 and
subsequent inflammatory responses; and (3) to assess
the effects of baicalin on mitochondrial dysfunction and
the apoptosis of TECs.
Methods
Experimental animals
Male Wistar rats weighing 200–250 g were housed in a
local facility for laboratory animal care and fed a stand-
ard diet and water, according to local ethical guidelines.
This study was approved by the Bioethics Committee
of Zhongshan Hospital, Fudan University, Shanghai, and
adhered to generally accepted international standards.
Renal ischemia-reperfusion model
Rats were randomly divided into five groups of six rats
each: (i) sham group; (ii) IR + saline group; (iii) IR +
baicalin (1 mg/kg) group; (iv) IR + baicalin (10 mg/kg)
group; and (v) IR + baicalin (100 mg/kg) group. Renal IRI
was induced by clamping the left renal artery for 45 min
plus a right nephrectomy [18]. Rats were anesthetized
through an intraperitoneal injection of pentobarbital
sodium (40 mg/kg body weight). After a median abdom-
inal incision, the left renal arteries were clamped for
45 min with serrefine. After clamp removal, adequate
restoration of blood flow was checked before abdominal
closure. The right kidney was then removed. Sham-operated
animals underwent the same surgical procedure without
clamping.Saline-treated animals received intraperitoneal injections
of 1 mL 0.9% sterile NaCl 30 min before renal clamping.
Baicalin-treated rats received intraperitoneal injections
of baicalin (Sigma), diluted in sterile saline to 1, 10, or
100 mg/kg body weight 30 min before renal clamping.
After the operation, the rats were kept on a warming
blanket for 12 h with food and water available. All ani-
mals were sacrificed 24 h after surgery with an overdose
of pentobarbital sodium, and their blood and kidneys
harvested.
Plasma biochemical analysis
Whole blood was centrifuged at 1600 g for 25 min at 4°C
to obtain serum. An autobiochemistry instrument (Hitachi
7060) was used to measure the levels of serum creatinine
(Scr) and blood urea nitrogen (BUN).
Histology
Renal tissue samples were fixed in 10% formalin for 24 h
and embedded in paraffin. The sections were stained with
hematoxylin and eosin and semi-quantitatively graded
at 200× magnification for tubular dilation and intersti-
tial expansion with edema, inflammatory infiltrate (TID)
on a scale of 0–3, with 0 indicating normal tubulointersti-
tium, and 1, 2, and 3 indicating mild (≤25%), moderate
(>25 to 50%), and severe (>50%) TID, respectively. Twelve
randomly selected fields of each sample were each exam-
ined by two blinded examiners, with the mean for each
kidney recorded [19].
Detection of apoptosis
Terminal deoxynucleotidyl transferase-mediated dUTP-
biotin nick end labeling (TUNEL) assay kit (KeyGEN) was
used to detect apoptotic cells according to the manufac-
turer’s instructions. Positive-control sections were from a
hepatocarcinoma. Apoptotic cells were examined at 400×
magnification over 20 fields of tubular areas [20].
Measurement of malondialdehyde content and
superoxide dismutase activity
Oxidative stress in the kidneys was assessed by measuring
the malondialdehyde (MDA) content and superoxide dis-
mutase (SOD) activity. MDA is a terminal product of lipid
peroxidation; its intracellular concentration was determined
with commercial kits (Beyotime), which used the thiobarbi-
turic acid method to form a red product with a maximum
absorbance at 535 nm. The results are reported as μmol
per milligram extracted protein. The activity of SOD in the
kidneys was detected using a Total Superoxide Dismutase
Assay Kit (Beyotime) and reported as U/mg protein.
Caspase-3 activity assays
Relative caspase-3 activity in kidney was detected with a
caspase-3 colorimetric assay kit (KeyGEN) according to
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measured at 405 nm with a microplate reader (Bio-Tek).
Western blot analysis
Cell lysates were prepared from 20 to 40 μg kidney tissue
and cytoplasmic protein was obtained by centrifugation
at 4°C. Equal aliquots of proteins were separated by
SDS-PAGE and transferred onto PVDF membranes. Pri-
mary antibodies were added and the membranes incu-
bated at 37°C for 2 h with gently shaking. The primary
antibodies included anti-TLR2 and anti-TLR4, both from
Abcam; and anti-MyD88, anti-NF-κB, anti-p-NF-κB, anti-
IκB, anti-p-IκB, anti-cleaved-caspase-3, anti-caspase-9,
anti-Bax, and anti-Bcl-2, all from Cell Signaling Tech-
nology. After thorough washing, the membranes were
incubated for 1 h at room temperature with peroxidase-
conjugated secondary antibodies (Jackson ImmunoRe-
search). Immunoreactive bands were visualized using an
ECL system (Amersham Pharmacia). To control for lane
loading, the same membranes were also incubated with
anti-β-actin antibody (Epitomics), depending on the mo-
lecular weight of target proteins. The signals were quanti-
fied by scanning densitometry using a Bio-Image Analysis
System (Bio-Rad), with each band normalized relative to
the actin band in the same sample. The results from each
experimental group were expressed as relative integrated
intensity compared with that of the control measured with
the same batch.
Quantitative real-time polymerase chain reaction
Total RNA was extracted from rat kidneys with TRIzol
reagent (Invitrogen, Shanghai, China) according to the
manufacturer’s instructions. Total RNA (3–5 μg) was
transcribed into cDNA by Superscript II reverse tran-
scriptase (Invitrogen) and random primer oligonucleo-
tides (Invitrogen). Our gene-specific primers for rat IL-1β,
IL-6, TNF-α, and GAPDH have been described [21].
Real-time quantitative polymerase chain reaction was
performed in a Bio-Rad iCycler iQ system in combination
with the Absolute QPCR SYBR Green premix (Takara Bio
Inc., Otsu, Shiga, Japan). After a hot start (15 min at 95°C),
the amplification protocol consisted of denaturation for
1 s at 95°C, annealing for 5 s at 60°C, and extension for
10 s at 72°C for 45 cycles. Expression levels were nor-
malized relative to those of GAPDH in the same samples
using the 2 −ΔΔCt method.
Statistical analyses
Data are presented as mean ± SEM. Results in two groups
were compared using two-tailed independent t-tests, and
results among three or more groups were compared by
one-way analysis of variance). All statistical analyses were
performed using SPSS 13.0 (SPSS Inc.), with P < 0.05
considered statistically significant.Results
Baicalin attenuated renal dysfunction, ameliorated renal
histologic damage, and decreased oxidative stress
induced by IRI
Rats that underwent renal IRI had showed significant in-
creases in Scr (79.67 vs. 18.00 μmol/L) and BUN (22.37 vs.
5.45 mmol/L) concentrations compared with the sham op-
erated group. Baicalin pretreatment dose-dependently pro-
tected against a loss of renal function, with the two higher
doses (10 and 100 mg/kg) significantly decreasing Scr and
BUN concentrations (Figure 1A). Histologic examination
showed tissue injuries after IRI (Figure 1B), including loss of
brush borders, dilation of renal tubules, and urinary cylin-
ders (Additional file 1: Figure S1). Tissue injury, as assessed
using a 0–3 point scoring system, was lower for the baicalin
treated groups than for the IR + saline group (Figure 1B).
Reoxygenation following ischemia causes tissue oxidative
stress, which is considered an important source of IRI. We
therefore investigated the effects of baicalin on oxidative
stress. Following ischemia reperfusion, MDA content was
greatly increased and SOD activity was greatly decreased in
kidneys, indicating increases in oxidative stress (Figure 1C).
Compared with the sham group, however, MDA content
was only slightly up-regulated and the SOD activity was
only slightly down-regulated in rats treated with 10 and
100 mg/kg baicalin, indicating that baicalin abrogated the
increase in oxidative stress following reperfusion.
Baicalin down-regulated the TLR2/4, MyD88, and NF-κB signaling,
and inhibited subsequent proinflammatory responses
The expression of proinflammatory cytokines (Figure 2A),
as well as TLR2/4 expression, were increased in kidneys
24 h after IRI. MyD88, a general adaptor protein of TLR2/4,
was also upregulated (Figure 2B). The activation/phosphor-
ylation and nuclear translocation of NF-κB, an important
downstream effector of TLR2/4 MyD88-dependent signal-
ing, has been found to enhance proinflammatory responses.
Increases in proinflammatory cytokines, including TNF-α
and IL-1β, would in turn promote the phosphorylation of
NF-κB. We therefore evaluated the levels of phosphoryl-
ation of NF-κB and IκB, both of which differed significantly
between in the IR + saline and sham groups (Figure 2C).
However, the expression of NF-κB was not affected.
Baicalin treatment inhibited the increased expression of
the proinflammatory cytokines TLR2/4, MyD88, p-NF-κB,
and p- IκB, as well as increase the expression of IκB
protein, an NF-κB inhibitor, with the degree of inhibition
positively related to the dosage of baicalin.
Baicalin prevented mitochondrial dysfunction,
down-regulated the activity of caspase-3, and
decreased the apoptosis of TECs following IRI
Baicalin significantly inhibited caspase-3 activity in kidneys
24 h after IRI (Figure 3A), as well as decreasing the
Figure 1 Effects of baicalin on renal function and histology 24 h after renal IRI. (A) Serum creatinine and blood urea nitrogen concentrations
were significantly higher in the IR + saline than in the sham group. Pretreatment with 10 or 100 mg/kg baicalin dose-dependently inhibited renal
dysfunction after renal IRI. (B) Baicalin amelioration of histological damage after IRI. (C) Baicalin reduction of MDA content and increase of SOD activity,
indicating that baicalin reduced oxidative stress. *P < 0.05, **P < 0.01, ***P < 0.001.
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IRI, compared with the IR + saline group. Western blot
assays of caspase-9, Bcl-2, and Bax proteins, which reflectmitochondrial stress, showed that baicalin dose-dependently
downregulated the expression of the pro-apoptotic proteins
caspase-9 and Bax, while upregulating the expression of the
Figure 2 Effects of baicalin on IRI induced proinflammatory response. (A) Baicalin inhibition of the IRI induced up-regulation of proinflammatory
cytokines. (B, C) Activation of the TLR2/4 signaling pathway by IRI, contributing to a proinflammatory response. Pretreatment with baicalin decreased
TLR2, TLR4, and MyD88 expression (B) and suppressed the phosphorylation of NF-κB and IκB (C), thereby inhibiting related proinflammatory signaling
pathways. *P < 0.05, **P < 0.01, ***P < 0.001.
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that baicalin inhibited mitochondria-mediated apoptosis.
TUNEL staining showed that most apoptotic cells were
located in tubular areas, with very few in interstitial areas
(Figure 3D). Treatment with 10 or 100 mg/kg baicalin
significantly reduced the number of apoptotic TECs.
Discussion
To our knowledge, this study is the first to provide in vivo
evidence of the potential therapeutic value of baicalin in
renal IRI. Baicalin pretreatment decreased oxidative stress
and inhibited proinflammatory response and immune-
mediated IRI. Moreover, baicalin ameliorated mitochon-
drial dysfunction and TEC apoptosis. Our findings suggest
that the mechanisms underlying this protection are largely
due to the inhibition of TLR2/4 and the NF-κB signaling
pathway and the deactivation of the mitochondrial stress
pathway (Figure 4).
Among the methods tested for attenuation of renal IRI
are many drugs [22,23], endocrine hormones [24], erythro-
poietin [21], and small interfering RNA [25]. Various
drawbacks, however, have prevented their clinical applica-
tion. It’s necessary to find a convenient, effective, and safemethod to treat renal IRI. Thus, the efficacy of baicalin
against kidney IRI was tested in our experiment.
In evaluating kidney function 24 h after surgery, we
found that baicalin pretreatment significantly reduced
serum Scr and BUN concentrations compared with the
IR + saline group, suggesting that baicalin protects kidneys
from IRI. HE staining also showed that baicalin amelio-
rated pathological damage to the kidneys.
IRI is an antigen-independent inflammatory process that
causes tissue damage [26,27]. Kidney IRI has been associ-
ated with multiple factors, including endothelial injury,
leukocyte infiltration, and tubular epithelial cell activation,
all of which trigger and exaggerate inflammation response
through the innate and adaptive immune systems [28,29].
The TLR2/4 signaling pathway is an important inflamma-
tory cascade after IRI. TLR2/4 are innate immune receptors
on cell surfaces. Myeloid differentiation factor 88 (MyD88),
an adaptor protein associated with activation of TLRs,
interacts with the IRAK complex, triggering further sig-
naling cascades, including the activation of NF-κB. The
nuclear translocation of NF-κB subsequently up-regulates
proinflammatory cytokines and chemokines [30]. TLR2
and TLR4 are constitutively expressed in proximal and
Figure 3 Effects of baicalin on IRI-induced mitochondrial dysfunction and cell apoptosis. (A, B) IRI upregulation of the activity
and expression of caspase-3 (17 kD, 12 kD) and its inhibition by baicalin. (C) Baicalin suppression of the renal IRI-induced increase in
mitochondrial stress, as shown by assays of expression of caspase-9, Bax, and Bcl-2. (D) TUNEL assay of apoptotic cells. Renal IRI
significantly increased the number of apoptotic cells, an increase significantly reduced by treatment with 10 and 100 mg/kg baicalin.
*P < 0.05, **P < 0.01, ***P < 0.001.
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collecting ducts, with both up-regulated in these sites after
IRI [31]. Consistent with these findings, we observed up-
regulation of TLR2 and TLR4 proteins in kidney resident
cells. The negative regulation of TLR signaling by baicalin
has been observed in lipopolysaccharide (LPS)-stimulated
human oral keratinocytes [32], oxygen-glucose deprived
rat microglial cells [33], and other ischemic organs [34].
Our findings suggest that baicalin treatment decreases
TLR2/4 activation and down-regulates the downstream
activation of NF-κB signaling in kidneys after IRI.
NF-κB activation can be measured by assays for p-NF-κB
and p-IκB. The transcription factor NF-κB, which is
inhibited by IκB binding, is involved in the expression
of proinflammatory genes [35]. NF-κB in response to IRIis activated via the phosphorylation of IκB, followed by
proteasome-mediated degradation. Subsequently, NF-κB
undergoes phosphorylation and translocates into the
nucleus, where it regulates the proinflammatory responses
[36]. Baicalin treatment reduced the expression of p-NF-κB
and p-IκB, while increasing the expression of IκB, which
inhibits NF-κB. Our results therefore suggest that baicalin
inhibited NF-κB activation during IRI.
Proinflammatory cytokines, including IL-1β, IL-6, and
TNF-α, are closely associated with renal IRI. High serum
concentrations of these cytokines are considered a marker
of severity. We found that the expression of these cytokines
was significantly increased after IRI, an increase positively
related to the activation of TLR2/4 and NF-κB signaling
(Figure 4).
Figure 4 Schematic diagram of signal pathways involved in renal IRI. Renal IRI induces oxidative stress and tissue injury, resulting in
mitochondrial dysfunction and activation of the TLR2/4 signaling pathway, all of which are targets of baicalin treatment.
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interrupts the redox balance, which is pivotal for normal
kidney function, and results in the accumulation of ROS.
Subsequent mitochondrial dysfunction may lead to TEC
apoptosis and loss of function [13,15,37]. The mitochon-
drion is the central organelle in the intrinsic pathway of
apoptosis [38,39]. Increased mitochondrial stress during
renal IRI up-regulates the Bax/Bcl-2 ratio and activates
mitochondria-mediated apoptosis. Increasing the Bax/Bcl-2
ratio will alter mitochondrial membrane permeability,
leading to the release of cytochrome C, which, together
with caspase-9, forms apoptosomes, subsequently activating
a downstream caspase cascade[14]. We found that baicalin
down-regulated Bax and up-regulated Bcl-2 expression,
further indicating that baicalin inhibits mitochondria-
mediated apoptosis (Figure 4). We also found that baicalin
downregulated the expression of caspase-9, an important
indicator of mitochondria-mediated apoptosis [40].
The results of TUNEL assays showed that apoptosis of
TECs was lower in baicalin treated than in IRI + saline-
treated animals. Decreased apoptosis is associated with
the deactivation of a caspase cascade. Caspase-3 is a
downstream effector in this cascade, directly mediating
apoptosis when activated by various upstream signals
[41], and regarded as a pivotal indicator of apoptosis
during IRI [19,42]. We found that baicalin significantly
inhibited the activation and activity of caspase-3.Conclusions
In summary, our study is the first to show that baicalin pre-
treatment can significantly ameliorate renal IRI, reduce the
expression of proinflammatory cytokines, and inhibit the
apoptosis of TECs by inhibiting the TLR2/4 signaling path-
way and the mitochondria-mediated cell apoptosis pathway.
Additional file
Additional file 1: Figure S1. Tissue injuries in renal IRI. Tissue injuries,
including loss of brush border, dilation of renal tubules, urinary cylinder
were obvious in the IR + saline group. Pretreatment with 10 or 100 mg/kg
baicalin reduced tissue injuries.→: bursh border; *: dilation of renal tubules;
▲: urinary cylinder.
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